UBS Group
BFRI icon

UBS Group’s Biofrontera BFRI Stock Holding History

UBS Group’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25K Sell
1,540
-8,825
-85% -$7.6K ﹤0.01% 9573
2025
Q4 		$5.91K Buy
10,365
+9,377
+949% +$8.47K ﹤0.01% 8611
2025
Q3 		$973 Sell
988
-13
-1% -$12 ﹤0.01% 9474
2025
Q2 		$713 Buy
1,001
+970
+3,129% +$678 ﹤0.01% 9757
2025
Q1 		$25 Sell
31
-14,042
-100% -$14.4K ﹤0.01% 10069
2024
Q4 		$15.3K Buy
14,073
+10,974
+354% +$10.4K ﹤0.01% 8050
2024
Q3 		$4.12K Sell
3,099
-6,918
-69% -$7.92K ﹤0.01% 8181
2024
Q2 		$8.99K Buy
+10,017
New +$13.8K ﹤0.01% 7766
2023
Q4 		– Sell
-1
Closed -$9 – 9315
2023
Q3 		$9 Buy
+1
New +$10 ﹤0.01% 9225
2023
Q2 		– Sell
-61
Closed -$739 – 8928
2023
Q1 		$739 Buy
+61
New +$951 ﹤0.01% 8919
2022
Q4 		– Sell
-237
Closed -$5K – 10731
2022
Q3 		$5K Buy
+237
New +$6.47K ﹤0.01% 9167

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group's BFRI Position: Q1 2026 in Review

UBS Group reduced its Biofrontera (BFRI) stake by 85% in Q1 2026, selling an estimated $7.6K and leaving 1,540 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #9573.

UBS Group first reported a position in BFRI in Q3 2022 and has held it in 11 quarters since. The position peaked at $15.3K in Q4 2024. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • UBS Group held 1,540 shares of Biofrontera worth $1.25K as of Q1 2026.
  • UBS Group sold 8,825 Biofrontera shares in Q1 2026, an estimated $7.6K.
  • Biofrontera made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9573 holding.
  • UBS Group first reported a position in Biofrontera in Q3 2022 and has held it in 11 quarters since.
  • UBS Group's Biofrontera position peaked at $15.3K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.